FARMACEUTISK MIDDEL INDEHOLDENDE DEN INSULIN-LIGNENDE VAEKSTFAKTOR II (IGF-II) TIL TOPISK ANVENDELSE TIL SAARHELING

There is described an invention for promoting the rate and improving the quality of wound healing by topically applying a pharmaceutical formulation comprising insulin-like growth factor-II.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SMITH, MICHELE CECEIL, SHAAR, CARL JOSEPH
Format:	Patent
Sprache:	dan
Schlagworte:	CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES CHEMISTRY DISINFECTION, STERILISATION, OR DEODORISATION OF AIR HUMAN NECESSITIES HYGIENE MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES MEDICAL OR VETERINARY SCIENCE METALLURGY METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	There is described an invention for promoting the rate and improving the quality of wound healing by topically applying a pharmaceutical formulation comprising insulin-like growth factor-II.